Antibe Therapeutics Inc. announced the formation of its Clinical Advisory Board with the appointment of three distinguished, internationally recognized gastroenterologists. The three appointees are: Dr. Francis Chan, Professor of Medicine at The Chinese University of Hong Kong; Dr. Angel Lanas, Professor of Medicine, University of Zaragoza (Spain); and Dr. James Scheiman, Professor of Internal Medicine at the University of Michigan. The company also announced that Jeremy Grushcow, Ph.D., J.D. has moved to a full-time position as EVP, Strategic Development.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.295 CAD | -.--% | -.--% | -68.28% |
04-24 | Antibe Therapeutics Inc. Announces Board Resignations | CI |
04-19 | Antibe Therapeutics Seeks Extension of Stay of Proceedings | MT |
1st Jan change | Capi. | |
---|---|---|
-68.28% | 11.47M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- ATE Stock
- News Antibe Therapeutics Inc.
- Antibe Therapeutics Inc. Announces the Formation of its Clinical Advisory Board